Affiliation:
1. Department of Chemistry, North Carolina State University, Raleigh, NC 27067, USA
Abstract
While cytochrome P450 (CYP; P450) enzymes are commonly associated with the metabolism of organic xenobiotics and drugs or the biosynthesis of organic signaling molecules, they are also impacted by a variety of inorganic species. Metallic nanoparticles, clusters, ions, and complexes can alter CYP expression, modify enzyme interactions with reductase partners, and serve as direct inhibitors. This commonly overlooked topic is reviewed here, with an emphasis on understanding the structural and physiochemical basis for these interactions. Intriguingly, while both organometallic and coordination compounds can act as potent CYP inhibitors, there is little evidence for the metabolism of inorganic compounds by CYPs, suggesting a potential alternative approach to evading issues associated with rapid modification and elimination of medically useful compounds.
Funder
National Institute of General Medical Sciences of the National Institutes of Health
Reference132 articles.
1. Cytochrome P450s and other enzymes in drug metabolism and toxicity;Guengerich;AAPS J.,2006
2. Zhao, M., Ma, J., Li, M., Zhang, Y., Jiang, B., Zhao, X., Huai, C., Shen, L., Zhang, N., and He, L. (2021). Cytochrome P450 Enzymes and Drug Metabolism in Humans. Int. J. Mol. Sci., 22.
3. Human drug metabolising cytochrome P450 enzymes: Properties and polymorphisms;Naunyn Schmiedeberg’s Arch. Pharmacol.,2004
4. Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases;Zordoky;Pharmacol. Ther.,2010
5. Metabolism pathways of arachidonic acids: Mechanisms and potential therapeutic targets;Wang;Signal Transduct. Target. Ther.,2021
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献